Skip Content
You are currently on the new version of our website. Access the old version .

Cells, Volume 14, Issue 15

2025 August-1 - 99 articles

Cover Story: Angiogenesis, as well as estrogen, is associated with cancer/tumor growth/progression. Our study uncovers a novel mechanism by which estradiol (E2) promotes human vascular endothelial cell proliferation, migration, and angiogenesis. We show that E2, via estrogen receptor /α/, post-transcriptionally downregulates anti-angiogenic microRNA-193a-3p levels, thereby activating PI3K/Akt–VEGF and ALK1/ID1 pathways. In vitro, miR-193a-3p suppression mimicked E2's pro-angiogenic effects, while its overexpression abrogated them. In vivo, miR-193a-3p mimic inhibited E2-induced capillary formation, highlighting miR-193a-3p as a potential therapeutic small molecule to target angiogenesis- and endothelial-driven pathologies. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (99)

  • Article
  • Open Access
3,818 Views
26 Pages

7 August 2025

The evolutionarily conserved Notch signalling pathway regulates the fate, proliferation and differentiation of cells in most developing organs, thus affecting their morphogenesis and function. Here, we investigated the role of the Notch2 receptor in...

  • Review
  • Open Access
4,776 Views
20 Pages

Exploiting TCR Repertoire Analysis to Select Therapeutic TCRs for Cancer Immunotherapy

  • Ursule M. Demaël,
  • Thunchanok Rirkkrai,
  • Fatma Zehra Okus,
  • Andreas Tiffeau-Mayer and
  • Hans J. Stauss

7 August 2025

Over the past decade, numerous innovative immunotherapy strategies have transformed the treatment of cancer and improved the survival of patients unresponsive to conventional chemotherapy and radiation therapy. Immune checkpoint inhibition approaches...

  • Article
  • Open Access
1,867 Views
22 Pages

IGF2BP3 as a Novel Prognostic Biomarker and Therapeutic Target in Lung Adenocarcinoma

  • Feiming Hu,
  • Chenchen Hu,
  • Yuanli He,
  • Lin Guo,
  • Yuanjie Sun,
  • Chenying Han,
  • Xiyang Zhang,
  • Junyi Ren,
  • Jinduo Han and
  • Shuya Yang
  • + 6 authors

7 August 2025

RNA-binding proteins (RBPs), particularly IGF2BP3, play critical but underexplored roles in lung adenocarcinoma (LUAD). This study investigated IGF2BP3′s clinical and functional significance using single-cell/RNA sequencing, validated by qPCR,...

  • Feature Paper
  • Article
  • Open Access
1 Citations
1,366 Views
18 Pages

B-Cell Lymphomas Secrete Novel Inhibitory Molecules That Disrupt HLA Class II-Mediated CD4+ T-Cell Recognition

  • Jason M. God,
  • Shereen Amria,
  • Christine A. Cameron,
  • Lixia Zhang,
  • Jennifer R. Bethard and
  • Azizul Haque

7 August 2025

B-cell lymphomas, including Burkitt lymphoma (BL), diffuse large B-cell lymphoma (DLBCL), and follicular lymphoma (FL), evade CD4+ T-cell immunity through novel HLA class II-associated immunosuppressive mechanisms. Despite expressing surface HLA-DR,...

  • Article
  • Open Access
2 Citations
1,616 Views
20 Pages

7 August 2025

Sepsis-induced myocardial injury is age-related and leads to increased mortality. Considering the importance of mitochondrial dysfunction in cardiac impairment, we aimed to investigate whether aging exacerbates the cardiac mitochondrial metabolic res...

  • Review
  • Open Access
2,760 Views
32 Pages

7 August 2025

Ischemic heart disease (IHD) represents a leading cause of global morbidity and mortality. Despite significant advances in treatment achieved over recent decades, as well as various therapeutic strategies available to manage IHD progression currently...

  • Review
  • Open Access
1 Citations
1,477 Views
38 Pages

Microbiome in Neuroblastoma: A Virgin Island in the World of Onco-Microbiome

  • Ashwath Keshav Giri,
  • Poorvi Subramanian,
  • Loganayaki Periyasamy,
  • Sivaroopan Aravindan and
  • Natarajan Aravindan

7 August 2025

The composition of the gut and/or tumor microbiome has been intricately involved in the onset of carcinogenesis, tumor progression, therapy response, and patient outcomes in diverse solid cancers. The microbiome type, composition, and their metabolom...

  • Review
  • Open Access
4 Citations
4,264 Views
21 Pages

Regenerative Cartilage Treatment for Focal Chondral Defects in the Knee: Focus on Marrow-Stimulating and Cell-Based Scaffold Approaches

  • Filippo Migliorini,
  • Francesco Simeone,
  • Tommaso Bardazzi,
  • Michael Kurt Memminger,
  • Gennaro Pipino,
  • Raju Vaishya and
  • Nicola Maffulli

7 August 2025

Focal chondral defects of the knee are a common cause of pain and functional limitation in active individuals and may predispose to early degenerative joint changes. Given the limited regenerative capacity of hyaline cartilage, biologically based sur...

  • Article
  • Open Access
1,270 Views
13 Pages

When Two Worlds Collide: The Contribution and Association Between Genetics (APOEε4) and Neuroinflammation (IL-1β) in Alzheimer’s Neuropathogenesis

  • Jagadeesh Narasimhappagari,
  • Ling Liu,
  • Meenakshisundaram Balasubramaniam,
  • Srinivas Ayyadevara and
  • W. Sue T. Griffin

7 August 2025

Introduction: Here we consider the collision of a genetic factor and an essential instigator in Alzheimer’s neuropathogenesis: (i) the Alzheimer’s gene (APOEε4), which downregulates lysosomal autophagy and induces synthesis of (ii...

  • Review
  • Open Access
1 Citations
2,956 Views
19 Pages

7 August 2025

Epidermolysis Bullosa (EB) comprises a group of inherited blistering disorders caused by pathogenic variants in genes essential for skin and mucosal integrity. Nonsense mutations, which generate premature termination codons (PTCs), result in reduced...

of 10

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cells - ISSN 2073-4409